This study was done at matay general hospital and El minia university hospital and include 90 
patients of low risk for PPH and did elective C S. patients were divided into THREE groups each 
group 30 patient (group A receive oxytocin by dose 20 IU, group B receive cabitocin by dose 100 
microgram, group C receive misoprostol by dose 880 microgram ) to compare efficacy and affiance
and incidace of side effects in three groups and according to results of this study amount of blood 
loss was less in cabitocin group than oxytocin and misoprostol and also side effects was less in 
cabitocin group.